Matthew Kelly

Matthew Kelly

Haug Partners LLP

Contact
View Bio
RSS

Latest Posts › Patent Invalidity

Share:

Federal Circuit Provides Further Guidance on Obvious Type Double Patenting For Patents Sharing Common Priority

On June 9th, 2025, the Federal Circuit issued a decision in Acadia Pharms. Inc. v. Aurobindo Pharma Ltd., affirming the district court’s grant of summary judgment of no invalidity for obviousness-type double patenting (OTDP)...more

7/7/2025  /  Abbreviated New Drug Application (ANDA) , Appeals , CAFC , Generic Drugs , Hatch-Waxman , Obviousness-Type Double Patenting (ODP) , Patent Invalidity , Patent Litigation , Pharmaceutical Industry , Pharmaceutical Patents
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide